The review found no eligible studies for this question.
Prevention of eclampsia: higher showed no clear difference in side effects compared with lower IV maintenance regimen (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether prevention of eclampsia: maintenance regimen by continuous infusion changes side effects compared with a serial IV bolus regimen (very low certainty).
It is very uncertain whether prevention of eclampsia: maintenance regimen by continuous infusion changes death of the baby before discharge: perinatal death compared with a serial IV bolus regimen (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether prevention of eclampsia: maintenance regimen by continuous infusion changes other neonatal morbidity: neonatal respiratory morbidity compared with a serial IV bolus regimen (very low certainty).
It is very uncertain whether treatment of eclampsia: lower‐dose regimens changes recurrence of convulsions: lower dose versus Pritchard regimen compared with standard‐dose regimens (very low certainty).
It is very uncertain whether treatment of eclampsia: lower‐dose regimens changes severe morbidity (renal failure): lower dose versus Pritchard regimen compared with standard‐dose regimens (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether the intervention changes fetal, neonatal and infant death (very low certainty).
The intervention may leads to lower respiratory distress syndrome (low certainty).